Fall Line Capital — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
Re-inventing immunotherapy for allergyukko.usinJul 2017
Ukko develops immuno-therapeutics for life-threatening food allergies using a computational protein design platform.
AI & Machine LearningBiotechDigital HealthMountain View, US
Anat Binur(Executive Officer, Director)Yanay Ofran(Director)Judith Weiss Paltiel(PhD, VP Development)
BoardScott Brady(Director)Samir Kaul(Director)in
Co-investorsIsrael Biotech FundKhosla VenturesSanara CapitalWestern Technology InvestmentLeaps by BayerPeakBridge VC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.